Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C4NF
|
||||
Former ID |
DIB007472
|
||||
Drug Name |
FMP-825
|
||||
Synonyms |
FMP-825; Obesity therapeutics, MDI; Anti-obesity agent, MDI; Beta-3 adrenoceptor agonist, Molecular Design International; Beta-3 adrenoceptor agonists (obesity/diabetes); Beta-3 adrenoceptor agonists (obesity/diabetes), MDI
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Investigative | [543754] | ||
Company |
Molecular Design International Inc
|
||||
Target and Pathway | |||||
Target(s) | Beta-3 adrenergic receptor | Target Info | Agonist | [543754] | |
References |
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.